Tifalibep

N/A

Report date: 2024/07/02 16:36:06

NME

Base Information

Drug NameTifalibep

Drug Alias NameABY-039

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAffibody Ab

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAffibody Ab

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A